scholarly journals P018 How to Improve Transition of Pediatric IBD Patients Through Use of EMR

2021 ◽  
Vol 116 (1) ◽  
pp. S4-S5
Author(s):  
Johnson Guylda ◽  
Walker Christopher ◽  
Miller John ◽  
Steiger Ashley ◽  
Bittner Krystle ◽  
...  
Keyword(s):  
2013 ◽  
Vol 7 ◽  
pp. S280
Author(s):  
C. Strisciuglio ◽  
E. Miele ◽  
M.E. Wildenberg ◽  
F.P. Giugliano ◽  
M. Andreozzi ◽  
...  

Author(s):  
Marla Dubinsky ◽  
Ling Mei ◽  
Carol Landers ◽  
Lirona Katzir ◽  
Sharmayne Farrior ◽  
...  

2006 ◽  
Vol 12 (4) ◽  
pp. 258-262 ◽  
Author(s):  
Ryan S. Carvalho ◽  
Vivian Abadom ◽  
Harrison P. Dilworth ◽  
Richard Thompson ◽  
Maria Oliva-Hemker ◽  
...  

2019 ◽  
Vol 12 (4) ◽  
pp. 355-361 ◽  
Author(s):  
Nienke Halbmeijer ◽  
Michael Groeneweg ◽  
Lissy De Ridder

2016 ◽  
Vol 19 (1) ◽  
pp. 215-222 ◽  
Author(s):  
Marla C. Dubinsky ◽  
Becky L. Phan ◽  
Namita Singh ◽  
Shervin Rabizadeh ◽  
Diane R. Mould

2017 ◽  
Vol 44 (11) ◽  
pp. 1636-1643 ◽  
Author(s):  
Osnat Nir ◽  
Firas Rinawi ◽  
Gil Amarilyo ◽  
Liora Harel ◽  
Raanan Shamir ◽  
...  

Objective.The natural history of pediatric inflammatory bowel disease (IBD) patients with joint involvement has not been clearly described. Thus, we aimed to investigate phenotypic features and clinical outcomes of this distinct association.Methods.The medical records of patients with pediatric IBD diagnosed from 2000 to 2016 were reviewed retrospectively. Main outcome measures included time to first flare, hospitalization, surgery, and biologic therapy.Results.Of 301 patients with Crohn disease (median age 14.2 yrs), 37 (12.3%) had arthritis while 44 (14.6%) had arthralgia at diagnosis. Arthritis and arthralgia were more common in women (p = 0.028). Patients with arthritis and arthralgia demonstrated lower rates of perianal disease (2.7% and 4.5% vs 16.9%, p = 0.013), whereas patients with arthritis were more likely to be treated with biologic therapy (HR 2.05, 95% CI 1.27–3.33, p = 0.009). Of 129 patients with ulcerative colitis (UC; median age 13.7 yrs), 3 (2.3%) had arthritis and 16 (12.4%) had arthralgia at diagnosis. Patients with arthralgia were treated more often with corticosteroids (p = 0.03) or immunomodulator therapies (p = 0.003) compared with those without joint involvement. The likelihood to undergo colectomy was significantly higher in patients with arthralgia (HR 2.9, 95% CI 1.1–7.4, p = 0.04). During followup (median 9.0 yrs), 13 patients developed arthritis (3.3%). Arthralgia at diagnosis was a significant predictor for the development of arthritis during followup (HR 9.0, 95% CI 2.86–28.5, p < 0.001).Conclusion.Pediatric IBD patients with arthritis have distinct phenotypic features. Arthralgia at diagnosis is a predictor for colectomy in UC and a risk factor for the development of arthritis during followup.


2018 ◽  
Vol 154 (6) ◽  
pp. S-1041
Author(s):  
James Markowitz ◽  
Jeffrey S. Hyams ◽  
Omoniyi J. Adedokun ◽  
Christopher Busse ◽  
James L. Izanec ◽  
...  

2018 ◽  
Vol 24 (10) ◽  
pp. 2135-2141 ◽  
Author(s):  
Ruben J Colman ◽  
Rachel C Lawton ◽  
Marla C Dubinsky ◽  
David T Rubin

Abstract Background Methotrexate (MTX) is an immunomodulator used for the treatment of pediatric inflammatory bowel disease (IBD). There are currently no RCTs that assess the treatment efficacy of methotrexate within the pediatric IBD patient population. This systematic review and meta-analysis assesses the efficacy of MTX therapy among the existing pediatric literature. Methods A systematic literature search was performed using MEDLINE and the Cochrane library from inception until March 2016. Synonyms for ‘pediatric’, ‘methotrexate’ and ‘IBD’ were utilized as both free text and MESH search terms. The studies included contained clinical remission (CR) rates for MTX treatment of pediatric IBD patients 18 yrs old, as mono- or combination therapy. Case studies with <10 patients were excluded. Quality assessment was performed with the Newcastle-Ottawa Scale. Meta-analysis calculated pooled CR rates. A random-effects meta-analysis with forest plots was performed using R. Results Fourteen (11 monotherapy, 1 combination therapy, 2 both; n = 886 patients) observational studies were eligible out of 202 studies. No interventional studies were identified. The pooled achieved CR rate for pediatric CD patients on monotherapy within 3-6 months was 57.7% (95% CI 48.2-66.6%), (P =0.22; I2 = 29.8%). The CR was 37.1% (95% CI 29.5-45.5%), (P = 0.20; I2 = 37.4%) for maintenance therapy at 12 months. Sub-analysis could not identify CR differences between MTX administration types, thiopurine exposure. Conclusions This meta-analysis demonstrated that, over 50% of pediatric Crohn’s disease patients induced with methotrexate achieved clinical remission, while 12-month remission rate was only 37%. Prospective controlled interventional trials should assess treatment efficacy among patient subgroups.


Sign in / Sign up

Export Citation Format

Share Document